Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells → androgen receptor (AR) → miRNA32 signals
Journal
Molecular Oncology
Journal Volume
9
Journal Issue
7
Pages
1241-1251
Date Issued
2015
Author(s)
SDGs
Publisher
Elsevier
Type
journal article